The WACC of Beam Therapeutics Inc (BEAM) is 8.3%.
Range | Selected | |
Cost of equity | 7.20% - 9.40% | 8.30% |
Tax rate | 26.20% - 27.00% | 26.60% |
Cost of debt | 7.00% - 7.50% | 7.25% |
WACC | 7.2% - 9.4% | 8.3% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.72 | 0.81 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 7.20% | 9.40% |
Tax rate | 26.20% | 27.00% |
Debt/Equity ratio | 0 | 0 |
Cost of debt | 7.00% | 7.50% |
After-tax WACC | 7.2% | 9.4% |
Selected WACC | 8.3% | |